Shalini Sharp - 14 Jan 2022 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
Director
Signature
/s/ Vickie Reed, Attorney-inFact
Issuer symbol
N/A
Transactions as of
14 Jan 2022
Net transactions value
$0
Form type
4
Filing time
18 Jan 2022, 17:17:13 UTC
Previous filing
08 Jun 2021
Next filing
20 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Award $0 +2,546 +105% $0.000000 4,970 14 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRTX Non Qualified Stock Option (right to buy) Award $0 +3,688 $0.000000 3,688 14 Jan 2022 Common Stock 3,688 $124.31 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of Restricted Stock Units (RSUs). Shares will vest 100% on the anniversary of the grant date.
F2 The shares subject to the Option vest and become exercisable in 12 equal monthly installments following the date of grant.